ATTO Attovia Therapeutics, Inc.
Nasdaq · SEC CIK 2058707 · EDGAR
- Bought, last 12 months
- $52.37M 7 purchases by 5 insiders
- Sold, last 12 months
- $4.50M 2 sales by 1 insiders
- Filings on record
- 14 since 2026-08-06, latest 2026-08-28 17:38
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| WALSH COLIN | Dir | $20.57M | $4.50M |
| Redmile Group, LLC | 10% | $10.20M | — |
| Frazier Life Sciences XI, L.P. | 10% | $10.00M | — |
| venBio Global Strategic Fund IV, L.P. | 10% | $6.50M | — |
| Sanofi | 10% | $5.10M | — |
| Deep Track Biotechnology Master Fund, Ltd. | 10% | — | — |
Transactions 16
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMAI | 2026-08-28 17:38 | 2026-08-05+ | ATTO | WALSH COLIN | Dir | P - Purchase | $17.58 | +585.0K | 3.02M | +24% | +$10.29M |
| DMAI | 2026-08-28 17:38 | 2026-08-05 | ATTO | WALSH COLIN | Dir | S - Sale | $21.28 | -105.8K | 0 | -100% | -$2.25M |
| DMAI | 2026-08-28 17:38 | 2026-08-06 | ATTO | WALSH COLIN | Dir | C - Cnv Deriv | $0.00 | +2.44M | 2.52M | +2,865% | $0 |
| DMI | 2026-08-13 21:52 | 2026-08-05+ | ATTO | WALSH COLIN | Dir | P - Purchase | $17.58 | +585.0K | 3.02M | +24% | +$10.29M |
| DMI | 2026-08-13 21:52 | 2026-08-05 | ATTO | WALSH COLIN | Dir | S - Sale | $21.28 | -105.8K | 0 | -100% | -$2.25M |
| DMI | 2026-08-13 21:52 | 2026-08-06 | ATTO | WALSH COLIN | Dir | C - Cnv Deriv | $0.00 | +2.44M | 2.52M | +2,865% | $0 |
| D | 2026-08-10 16:30 | 2026-08-06 | ATTO | Deep Track Biotechnology Master Fund, Ltd. | 10% | C - Cnv Deriv | — | +1.96M | 1.96M | New | — |
| DM | 2026-08-10 16:12 | 2026-08-06 | ATTO | venBio Global Strategic Fund IV, L.P. | 10% | C - Cnv Deriv | — | +3.80M | 3.80M | New | — |
| D | 2026-08-10 16:12 | 2026-08-06 | ATTO | venBio Global Strategic Fund IV, L.P. | 10% | P - Purchase | $17.00 | +382.4K | 4.18M | +10% | +$6.50M |
| DI | 2026-08-07 21:47 | 2026-08-06 | ATTO | Redmile Group, LLC | 10% | C - Cnv Deriv | — | +782.9K | 782.9K | New | — |
| D | 2026-08-07 21:47 | 2026-08-06 | ATTO | Redmile Group, LLC | 10% | P - Purchase | $17.00 | +200.0K | 982.9K | +26% | +$3.40M |
| DI | 2026-08-07 21:47 | 2026-08-06 | ATTO | Redmile Group, LLC | 10% | P - Purchase | $17.00 | +400.0K | 1.18M | +51% | +$6.80M |
| DI | 2026-08-07 15:45 | 2026-08-06 | ATTO | Sanofi | 10% | C - Cnv Deriv | — | +782.9K | 782.9K | New | — |
| DI | 2026-08-07 15:45 | 2026-08-06 | ATTO | Sanofi | 10% | P - Purchase | $17.00 | +300.0K | 1.08M | +38% | +$5.10M |
| DM | 2026-08-06 17:35 | 2026-08-06 | ATTO | Frazier Life Sciences XI, L.P. | 10% | C - Cnv Deriv | — | +5.49M | 5.57M | +7,287% | — |
| D | 2026-08-06 17:35 | 2026-08-06 | ATTO | Frazier Life Sciences XI, L.P. | 10% | P - Purchase | $17.00 | +588.2K | 6.15M | +11% | +$10.00M |
Purchase Sale Sale after option exercise All abbreviations